| Dr Mircea Cristian Dobre, MD MS | |
|
41 Mall Rd, Burlington, MA 01805-2149 | |
| (781) 744-8085 | |
| Not Available |
| Full Name | Dr Mircea Cristian Dobre |
|---|---|
| Gender | Male |
| Speciality | Diagnostic Radiology |
| Experience | 18 Years |
| Location | 41 Mall Rd, Burlington, Massachusetts |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1225203151 | NPI | - | NPPES |
| Facility Name | Location | Facility Type |
|---|---|---|
| Lahey Hospital & Medical Center, Burlington | Burlington, MA | Hospital |
| Northeast Hospital Corporation | Beverly, MA | Hospital |
| Beth Israel Deaconess Medical Center | Boston, MA | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Lahey Clinic Inc | 2264336528 | 1211 |
News Archive
In this post on the Center for Global Development's (CGD) "Global Health Policy" blog, Amanda Glassman, a research fellow and director of global health policy at CGD, explains why the banking background of the new general manager of the Global Fund to Fight AIDS, Tuberculosis and Malaria, Gabriel Jaramillo, "should serve him well."
Optimer Pharmaceuticals, Inc. today announced positive top-line results from the second of two pivotal Phase 3 trials evaluating the safety and efficacy of fidaxomicin (OPT-80) in patients with Clostridium difficile Infection (CDI). This study was conducted in approximately 100 clinical sites throughout North America and Europe. The Company plans to use data from this study to support submission of a New Drug Application (NDA) to the U.S. Food and Drug Administration (FDA) in the second half of 2010.
R-Tech Ueno supplies Amitiza (TM) Capsules to Takeda pursuant to agreements with Takeda and Sucampo. On March 12, 2010, Sucampo submitted for filing with the International Court of Arbitration, International Chamber of Commerce, a Request for Arbitration against Takeda. In that Request, Sucampo claimed that Takeda has violated the provisions of the October 29, 2004, Collaboration and License Agreement between Sucampo and Takeda and other applicable duties, and that Takeda's violations have injured Sucampo. Sucampo requested all appropriate relief, including termination of the agreements, damages remedy and so on.
The Providence Service Corporation, a leader in the management and provision of human social services, innovative global employment services and non-emergency transportation through a variety of government-sponsored programs, announced today that it has entered into an agreement to acquire CCHN Group Holdings, Inc. ("Matrix Medical Network" or "Matrix"), a Scottsdale, Arizona provider of in-home health assessment and care management services and a portfolio company of Welsh, Carson, Anderson & Stowe XI, L.P. ("Welsh Carson").
Amid reports that an increasing number of Americans are living below the poverty level, UCLA/Johnson & Johnson Health Care Institute (HCI) is expanding its efforts to help low-income families.
› Verified 7 days ago
| Entity Name | Lahey Clinic Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1538194980 PECOS PAC ID: 2264336528 Enrollment ID: O20031120000097 |
News Archive
In this post on the Center for Global Development's (CGD) "Global Health Policy" blog, Amanda Glassman, a research fellow and director of global health policy at CGD, explains why the banking background of the new general manager of the Global Fund to Fight AIDS, Tuberculosis and Malaria, Gabriel Jaramillo, "should serve him well."
Optimer Pharmaceuticals, Inc. today announced positive top-line results from the second of two pivotal Phase 3 trials evaluating the safety and efficacy of fidaxomicin (OPT-80) in patients with Clostridium difficile Infection (CDI). This study was conducted in approximately 100 clinical sites throughout North America and Europe. The Company plans to use data from this study to support submission of a New Drug Application (NDA) to the U.S. Food and Drug Administration (FDA) in the second half of 2010.
R-Tech Ueno supplies Amitiza (TM) Capsules to Takeda pursuant to agreements with Takeda and Sucampo. On March 12, 2010, Sucampo submitted for filing with the International Court of Arbitration, International Chamber of Commerce, a Request for Arbitration against Takeda. In that Request, Sucampo claimed that Takeda has violated the provisions of the October 29, 2004, Collaboration and License Agreement between Sucampo and Takeda and other applicable duties, and that Takeda's violations have injured Sucampo. Sucampo requested all appropriate relief, including termination of the agreements, damages remedy and so on.
The Providence Service Corporation, a leader in the management and provision of human social services, innovative global employment services and non-emergency transportation through a variety of government-sponsored programs, announced today that it has entered into an agreement to acquire CCHN Group Holdings, Inc. ("Matrix Medical Network" or "Matrix"), a Scottsdale, Arizona provider of in-home health assessment and care management services and a portfolio company of Welsh, Carson, Anderson & Stowe XI, L.P. ("Welsh Carson").
Amid reports that an increasing number of Americans are living below the poverty level, UCLA/Johnson & Johnson Health Care Institute (HCI) is expanding its efforts to help low-income families.
› Verified 7 days ago
| Entity Name | Lahey Clinic Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1063447316 PECOS PAC ID: 2264336528 Enrollment ID: O20040629001269 |
News Archive
In this post on the Center for Global Development's (CGD) "Global Health Policy" blog, Amanda Glassman, a research fellow and director of global health policy at CGD, explains why the banking background of the new general manager of the Global Fund to Fight AIDS, Tuberculosis and Malaria, Gabriel Jaramillo, "should serve him well."
Optimer Pharmaceuticals, Inc. today announced positive top-line results from the second of two pivotal Phase 3 trials evaluating the safety and efficacy of fidaxomicin (OPT-80) in patients with Clostridium difficile Infection (CDI). This study was conducted in approximately 100 clinical sites throughout North America and Europe. The Company plans to use data from this study to support submission of a New Drug Application (NDA) to the U.S. Food and Drug Administration (FDA) in the second half of 2010.
R-Tech Ueno supplies Amitiza (TM) Capsules to Takeda pursuant to agreements with Takeda and Sucampo. On March 12, 2010, Sucampo submitted for filing with the International Court of Arbitration, International Chamber of Commerce, a Request for Arbitration against Takeda. In that Request, Sucampo claimed that Takeda has violated the provisions of the October 29, 2004, Collaboration and License Agreement between Sucampo and Takeda and other applicable duties, and that Takeda's violations have injured Sucampo. Sucampo requested all appropriate relief, including termination of the agreements, damages remedy and so on.
The Providence Service Corporation, a leader in the management and provision of human social services, innovative global employment services and non-emergency transportation through a variety of government-sponsored programs, announced today that it has entered into an agreement to acquire CCHN Group Holdings, Inc. ("Matrix Medical Network" or "Matrix"), a Scottsdale, Arizona provider of in-home health assessment and care management services and a portfolio company of Welsh, Carson, Anderson & Stowe XI, L.P. ("Welsh Carson").
Amid reports that an increasing number of Americans are living below the poverty level, UCLA/Johnson & Johnson Health Care Institute (HCI) is expanding its efforts to help low-income families.
› Verified 7 days ago
| Entity Name | Commonwealth Radiology Associates Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1295711661 PECOS PAC ID: 2668468406 Enrollment ID: O20081210000048 |
News Archive
In this post on the Center for Global Development's (CGD) "Global Health Policy" blog, Amanda Glassman, a research fellow and director of global health policy at CGD, explains why the banking background of the new general manager of the Global Fund to Fight AIDS, Tuberculosis and Malaria, Gabriel Jaramillo, "should serve him well."
Optimer Pharmaceuticals, Inc. today announced positive top-line results from the second of two pivotal Phase 3 trials evaluating the safety and efficacy of fidaxomicin (OPT-80) in patients with Clostridium difficile Infection (CDI). This study was conducted in approximately 100 clinical sites throughout North America and Europe. The Company plans to use data from this study to support submission of a New Drug Application (NDA) to the U.S. Food and Drug Administration (FDA) in the second half of 2010.
R-Tech Ueno supplies Amitiza (TM) Capsules to Takeda pursuant to agreements with Takeda and Sucampo. On March 12, 2010, Sucampo submitted for filing with the International Court of Arbitration, International Chamber of Commerce, a Request for Arbitration against Takeda. In that Request, Sucampo claimed that Takeda has violated the provisions of the October 29, 2004, Collaboration and License Agreement between Sucampo and Takeda and other applicable duties, and that Takeda's violations have injured Sucampo. Sucampo requested all appropriate relief, including termination of the agreements, damages remedy and so on.
The Providence Service Corporation, a leader in the management and provision of human social services, innovative global employment services and non-emergency transportation through a variety of government-sponsored programs, announced today that it has entered into an agreement to acquire CCHN Group Holdings, Inc. ("Matrix Medical Network" or "Matrix"), a Scottsdale, Arizona provider of in-home health assessment and care management services and a portfolio company of Welsh, Carson, Anderson & Stowe XI, L.P. ("Welsh Carson").
Amid reports that an increasing number of Americans are living below the poverty level, UCLA/Johnson & Johnson Health Care Institute (HCI) is expanding its efforts to help low-income families.
› Verified 7 days ago
| Entity Name | Chelmsford Mri Pc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1821435553 PECOS PAC ID: 9537118609 Enrollment ID: O20130926000109 |
News Archive
In this post on the Center for Global Development's (CGD) "Global Health Policy" blog, Amanda Glassman, a research fellow and director of global health policy at CGD, explains why the banking background of the new general manager of the Global Fund to Fight AIDS, Tuberculosis and Malaria, Gabriel Jaramillo, "should serve him well."
Optimer Pharmaceuticals, Inc. today announced positive top-line results from the second of two pivotal Phase 3 trials evaluating the safety and efficacy of fidaxomicin (OPT-80) in patients with Clostridium difficile Infection (CDI). This study was conducted in approximately 100 clinical sites throughout North America and Europe. The Company plans to use data from this study to support submission of a New Drug Application (NDA) to the U.S. Food and Drug Administration (FDA) in the second half of 2010.
R-Tech Ueno supplies Amitiza (TM) Capsules to Takeda pursuant to agreements with Takeda and Sucampo. On March 12, 2010, Sucampo submitted for filing with the International Court of Arbitration, International Chamber of Commerce, a Request for Arbitration against Takeda. In that Request, Sucampo claimed that Takeda has violated the provisions of the October 29, 2004, Collaboration and License Agreement between Sucampo and Takeda and other applicable duties, and that Takeda's violations have injured Sucampo. Sucampo requested all appropriate relief, including termination of the agreements, damages remedy and so on.
The Providence Service Corporation, a leader in the management and provision of human social services, innovative global employment services and non-emergency transportation through a variety of government-sponsored programs, announced today that it has entered into an agreement to acquire CCHN Group Holdings, Inc. ("Matrix Medical Network" or "Matrix"), a Scottsdale, Arizona provider of in-home health assessment and care management services and a portfolio company of Welsh, Carson, Anderson & Stowe XI, L.P. ("Welsh Carson").
Amid reports that an increasing number of Americans are living below the poverty level, UCLA/Johnson & Johnson Health Care Institute (HCI) is expanding its efforts to help low-income families.
› Verified 7 days ago
| Entity Name | Merrimack Radiology-cra Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1275871154 PECOS PAC ID: 8426287269 Enrollment ID: O20140128000095 |
News Archive
In this post on the Center for Global Development's (CGD) "Global Health Policy" blog, Amanda Glassman, a research fellow and director of global health policy at CGD, explains why the banking background of the new general manager of the Global Fund to Fight AIDS, Tuberculosis and Malaria, Gabriel Jaramillo, "should serve him well."
Optimer Pharmaceuticals, Inc. today announced positive top-line results from the second of two pivotal Phase 3 trials evaluating the safety and efficacy of fidaxomicin (OPT-80) in patients with Clostridium difficile Infection (CDI). This study was conducted in approximately 100 clinical sites throughout North America and Europe. The Company plans to use data from this study to support submission of a New Drug Application (NDA) to the U.S. Food and Drug Administration (FDA) in the second half of 2010.
R-Tech Ueno supplies Amitiza (TM) Capsules to Takeda pursuant to agreements with Takeda and Sucampo. On March 12, 2010, Sucampo submitted for filing with the International Court of Arbitration, International Chamber of Commerce, a Request for Arbitration against Takeda. In that Request, Sucampo claimed that Takeda has violated the provisions of the October 29, 2004, Collaboration and License Agreement between Sucampo and Takeda and other applicable duties, and that Takeda's violations have injured Sucampo. Sucampo requested all appropriate relief, including termination of the agreements, damages remedy and so on.
The Providence Service Corporation, a leader in the management and provision of human social services, innovative global employment services and non-emergency transportation through a variety of government-sponsored programs, announced today that it has entered into an agreement to acquire CCHN Group Holdings, Inc. ("Matrix Medical Network" or "Matrix"), a Scottsdale, Arizona provider of in-home health assessment and care management services and a portfolio company of Welsh, Carson, Anderson & Stowe XI, L.P. ("Welsh Carson").
Amid reports that an increasing number of Americans are living below the poverty level, UCLA/Johnson & Johnson Health Care Institute (HCI) is expanding its efforts to help low-income families.
› Verified 7 days ago
| Entity Name | Mass General Brigham Community Physicians Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1891112637 PECOS PAC ID: 1759273436 Enrollment ID: O20150723007726 |
News Archive
In this post on the Center for Global Development's (CGD) "Global Health Policy" blog, Amanda Glassman, a research fellow and director of global health policy at CGD, explains why the banking background of the new general manager of the Global Fund to Fight AIDS, Tuberculosis and Malaria, Gabriel Jaramillo, "should serve him well."
Optimer Pharmaceuticals, Inc. today announced positive top-line results from the second of two pivotal Phase 3 trials evaluating the safety and efficacy of fidaxomicin (OPT-80) in patients with Clostridium difficile Infection (CDI). This study was conducted in approximately 100 clinical sites throughout North America and Europe. The Company plans to use data from this study to support submission of a New Drug Application (NDA) to the U.S. Food and Drug Administration (FDA) in the second half of 2010.
R-Tech Ueno supplies Amitiza (TM) Capsules to Takeda pursuant to agreements with Takeda and Sucampo. On March 12, 2010, Sucampo submitted for filing with the International Court of Arbitration, International Chamber of Commerce, a Request for Arbitration against Takeda. In that Request, Sucampo claimed that Takeda has violated the provisions of the October 29, 2004, Collaboration and License Agreement between Sucampo and Takeda and other applicable duties, and that Takeda's violations have injured Sucampo. Sucampo requested all appropriate relief, including termination of the agreements, damages remedy and so on.
The Providence Service Corporation, a leader in the management and provision of human social services, innovative global employment services and non-emergency transportation through a variety of government-sponsored programs, announced today that it has entered into an agreement to acquire CCHN Group Holdings, Inc. ("Matrix Medical Network" or "Matrix"), a Scottsdale, Arizona provider of in-home health assessment and care management services and a portfolio company of Welsh, Carson, Anderson & Stowe XI, L.P. ("Welsh Carson").
Amid reports that an increasing number of Americans are living below the poverty level, UCLA/Johnson & Johnson Health Care Institute (HCI) is expanding its efforts to help low-income families.
› Verified 7 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Mircea Cristian Dobre, MD MS 401 Bicentennial Way, Santa Rosa, CA 95403-2149 Ph: () - | Dr Mircea Cristian Dobre, MD MS 41 Mall Rd, Burlington, MA 01805-2149 Ph: (781) 744-8085 |
News Archive
In this post on the Center for Global Development's (CGD) "Global Health Policy" blog, Amanda Glassman, a research fellow and director of global health policy at CGD, explains why the banking background of the new general manager of the Global Fund to Fight AIDS, Tuberculosis and Malaria, Gabriel Jaramillo, "should serve him well."
Optimer Pharmaceuticals, Inc. today announced positive top-line results from the second of two pivotal Phase 3 trials evaluating the safety and efficacy of fidaxomicin (OPT-80) in patients with Clostridium difficile Infection (CDI). This study was conducted in approximately 100 clinical sites throughout North America and Europe. The Company plans to use data from this study to support submission of a New Drug Application (NDA) to the U.S. Food and Drug Administration (FDA) in the second half of 2010.
R-Tech Ueno supplies Amitiza (TM) Capsules to Takeda pursuant to agreements with Takeda and Sucampo. On March 12, 2010, Sucampo submitted for filing with the International Court of Arbitration, International Chamber of Commerce, a Request for Arbitration against Takeda. In that Request, Sucampo claimed that Takeda has violated the provisions of the October 29, 2004, Collaboration and License Agreement between Sucampo and Takeda and other applicable duties, and that Takeda's violations have injured Sucampo. Sucampo requested all appropriate relief, including termination of the agreements, damages remedy and so on.
The Providence Service Corporation, a leader in the management and provision of human social services, innovative global employment services and non-emergency transportation through a variety of government-sponsored programs, announced today that it has entered into an agreement to acquire CCHN Group Holdings, Inc. ("Matrix Medical Network" or "Matrix"), a Scottsdale, Arizona provider of in-home health assessment and care management services and a portfolio company of Welsh, Carson, Anderson & Stowe XI, L.P. ("Welsh Carson").
Amid reports that an increasing number of Americans are living below the poverty level, UCLA/Johnson & Johnson Health Care Institute (HCI) is expanding its efforts to help low-income families.
› Verified 7 days ago
David A Rosman, M.D. Radiology Medicare: Accepting Medicare Assignments Practice Location: Lahey Clinic, 41 Mall Road, Burlington, MA 01805 Phone: 781-744-8170 | |
Dr. Jonathan Rassi, M.D. Radiology Medicare: Accepting Medicare Assignments Practice Location: 41 Mall Road, Lahey Hospital & Medical Center, Burlington, MA 01805 Phone: 781-744-8170 Fax: 781-744-5232 | |
Dr. Richard Thomas, M.D. Radiology Medicare: Accepting Medicare Assignments Practice Location: Lahey Hospital & Medical Center, 41 Mall Road, Burlington, MA 01805 Phone: 781-744-8170 Fax: 781-744-5232 | |
Patricia M. Morris, M.D. Radiology Medicare: Medicare Enrolled Practice Location: Lahey Clinic, 41 Mall Road, Burlington, MA 01805 Phone: 781-744-5100 Fax: 781-744-5215 | |
Laura Cadogan, Radiology Medicare: Accepting Medicare Assignments Practice Location: 41 Mall Rd, Burlington, MA 01805 Phone: 781-744-5114 | |
Reza Hakimelahi, M.D. Radiology Medicare: Accepting Medicare Assignments Practice Location: 41 Mall Rd, Burlington, MA 01805 Phone: 781-744-8000 Fax: 781-744-3707 | |
Dr. Grace M. Lee, M.D. Radiology Medicare: Accepting Medicare Assignments Practice Location: Lahey Clinic, 41 Mall Road, Burlington, MA 01805 Phone: 781-744-8170 Fax: 781-744-5232 |